Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Notes Payables (2017 - 2025)

Cosmos Health's Notes Payables history spans 10 years, with the latest figure at $2.1 million for Q4 2025.

  • Quarterly results put Notes Payables at $2.1 million for Q4 2025, up 466.66% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (up 466.66% YoY), and the annual figure for FY2025 was $2.1 million, up 466.66%.
  • Notes Payables for Q4 2025 was $2.1 million at Cosmos Health, down from $3.6 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $15.1 million in Q3 2021 to a low of $377264.0 in Q4 2024.
  • The 5-year median for Notes Payables is $1.5 million (2024), against an average of $3.0 million.
  • The sharpest move saw Notes Payables soared 2951.9% in 2021, then crashed 97.34% in 2022.
  • Year by year, Notes Payables stood at $15.1 million in 2021, then plummeted by 66.78% to $5.0 million in 2022, then fell by 8.21% to $4.6 million in 2023, then crashed by 91.81% to $377264.0 in 2024, then skyrocketed by 466.66% to $2.1 million in 2025.
  • According to Business Quant data, Notes Payables over the past three periods came in at $2.1 million, $3.6 million, and $5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.